Oncomatryx, Award for Innovation and Digitalization at the 9th edition of the National SME of the Year Award
A total of 1,770 companies participated in the ninth edition of the National SME of the Year Award.
The award was presented to Laureano Simón, founder of Oncomatryx, at a ceremony held in Madrid.
This recognition confirms Oncomatryx’s innovation in the field of oncology and represents a hopeful milestone in the fight against cancer.
Oncomatryx received the Innovation and Digitalization Award at the ninth edition of the National SME of the Year Award, organized by Banco Santander and the Spanish Chamber of Commerce. King Felipe VI presented the award to Laureano Simón, founder of the company, at a ceremony held in Madrid.
A total of 1,770 companies from across the country participated in this ninth edition, consolidating these awards as one of the most important business recognitions for the SME sector in Spain.
This award recognizes Oncomatryx’s commitment to research and development of innovative treatments for solid cancers. This work drives scientific progress and represents hope for people suffering from this disease.
It reinforces Oncomatryx’s position as a leading biotechnology company in the field of oncology, endorsing its commitment to innovation, scientific excellence, and improving the quality of life of patients.
